Related Experiment Video
Updated: Sep 18, 2025

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
Genistein and Vanadate Differentially Modulate Cortical GABAA Receptor/ATPase Activity and Behavior in Rats via a
Sergey A Menzikov1, Danila M Zaichenko1, Aleksey A Moskovtsev1
1Institute of General Pathology and Pathophysiology, 8, Baltiyskaya St., Moscow 125315, Russia.
Genistein and vanadate show opposing effects on GABAA receptor and ATPase activity, influencing neuronal anion transport. Genistein alleviates phenol-induced adverse effects, highlighting their interaction in synaptic plasticity regulation.
Area of Science:
- Neuroscience
- Molecular Biology
- Biochemistry
Background:
- GABAA receptors mediate anion flux, but coordination between passive and active transport remains unclear.
- Tyrosine kinase and phosphatase inhibitors modulate neuronal function, impacting ion homeostasis.
Purpose of the Study:
- Investigate genistein and vanadate roles in GABAAR-mediated anion changes and ATPase activity.
- Elucidate the molecular mechanisms of passive and active anion transport coordination.
Main Methods:
- Fluorescence measurements in rat cortical neurons and HEK 293FT cells.
- Assessed GABAAR-mediated chloride and bicarbonate changes.
- Evaluated ATPase activity and effects of genistein, vanadate, and phenol.
Main Results:
- Genistein inhibited passive GABAAR chloride influx and chloride ATPase activity.
- Vanadate inhibited chloride, bicarbonate ATPase activity, and bicarbonate recovery.
- Phenol reversed blocker effects; genistein mitigated phenol-induced adverse effects in rats.
Conclusions:
- Genistein and vanadate have opposing roles in GABAAR/ATPase function, modulating bicarbonate-dependent transport.
- These systems act as bistable elements in synaptic plasticity regulation.
- Demonstrated interaction between genistein, vanadate, and phenol at receptor binding sites.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
GPCRs Regulate Adenylyl Cylase Activity
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Activation and Inactivation of G Proteins
GPCR Desensitization

